Iterum TherapeuticsITRMF
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 20 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 5 from Q3 2024. 9 opened new positions and 5 sold out. The largest holders were Renaissance Technologies ($777K), New Leaf Venture Partners, L.L.C. ($611K) and Apollon Financial, LLC ($443K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $939K |
| Exits | 5 | $1.5M |
All 13F filers, Q3 2024 → Q4 2024: 567,578 shares bought and 1,437,823 shares sold, net −870,245 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Renaissance Technologies | 0.00% | New | 438,816 | $777K |
| New Leaf Venture Partners, L.L.C. | 0.82% | No change | 345,020 | $611K |
| Apollon Financial, LLC | 0.11% | Add +11.3% | 250,250 | $443K |
| Two Sigma Investments, LP | 0.00% | New | 25,245 | $45K |
| Citadel Advisors | 0.00% | New | 21,207 | $38K |
| Sanctuary Advisors, LLC | 0.00% | New | 20,000 | $31K |
| Lee Financial Co | 0.00% | New | 16,000 | $28K |
| Alpine Global Management, LLC | 0.01% | Reduce -76.9% | 15,000 | $27K |
| Geode Capital Management, LLC | 0.00% | No change | 12,370 | $22K |
| Morgan Stanley | 0.00% | Add +114.1% | 11,729 | $21K |
| Jane Street Group, LLC | 0.00% | New | 10,262 | $18K |
| UBS Group AG | 0.00% | Add +307300.0% | 3,074 | $5K |
| Medallion Wealth Advisors, LLC | 0.00% | — | 1,680 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 710 | $1K |
| Barclays PLC | 0.00% | New | 500 | $885 |
| Activest Wealth Management | 0.00% | No change | 133 | $235 |
| Wells Fargo & Company | 0.00% | No change | 85 | $150 |
| NFSG Corp | 0.00% | New | 15 | $27 |
| SBI Securities Co., Ltd. | 0.00% | — | 14 | $25 |
| HM Payson & Co. | 0.00% | No change | 3 | $6 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.